<DOC>
	<DOCNO>NCT01807338</DOCNO>
	<brief_summary>The purpose study document long-term safety tolerability intracerebroventricular ( ICV ) administration sNN0031 ( PDGF-BB ) patient participate study sNN0031-001</brief_summary>
	<brief_title>A Follow-up Study Safety Tolerability Intracerebroventricular Administration sNN0031 Patients With Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Previous participation study sNN0031001 completion 12 study week without development clinically significant safety concern , define drugrelated device relate serious adverse event result premature termination treatment medical device incident could resolve conduct study sNN0031001 The patient diagnosis idiopathic PD The patient give write verbal information followup study , opportunity ask question study , understands time procedural commitment The patient provide write informed consent participate followup study The patient include participate another clinical study participation Study sNN0031001 The patient , since participation study sNN0031001 , functional neurosurgical treatment PD ( e.g. , deep brain stimulation ) . Patients exclude participation event laboratory test abnormality indicative medical condition require treatment , opinion investigator , compatible participation present study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>